Novel genetic alterations and their impact on target therapy response in head and neck squamous cell carcinoma

References

• BrauswetterDDánosKGurbiBCopy number gain of PIK3CA and Met is associated with poor prognosis in head and neck squamous cell carcinomaVirchows Arch2016468557958726832731
   PubMed Web of Science ®Google Scholar
• WalterVYinXWilkersonMDMolecular subtypes in head and neck cancer exhibit distinct patterns of chromosomal gain and loss of canonical cancer genesPLoS One201382e5682323451093
   PubMed Web of Science ®Google Scholar
• [No authors listed]TCGA releases head and neck cancer dataCancer Discov201554340341
   Web of Science ®Google Scholar
• LawrenceMSSougnezCLichtensteinLCancer Genome Atlas NetworkComprehensive genomic characterization of head and neck squamous cell carcinomasNature2015517753657658225631445
   PubMed Web of Science ®Google Scholar
• HymanDMSolitDBArcilaMEPrecision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trialsDrug Discov Today201520121422142826320725
   PubMed Web of Science ®Google Scholar
• MorrisLGChandramohanRWestLThe molecular landscape of recurrent and metastatic head and neck cancers: insights from a precision oncology sequencing platformJAMA Oncol201732244255
   PubMed Web of Science ®Google Scholar
• ZhouGLiuZMyersJNTP53 mutations in head and neck squamous cell carcinoma and their impact on disease progression and treatment responseJ Cell Biochem2016117122682269227166782
   PubMed Web of Science ®Google Scholar
• WeissJHayesDNClassifying squamous cell carcinoma of the head and neck: prognosis, prediction and implications for therapyExpert Rev Anticancer Ther201414222923624313652
   PubMed Web of Science ®Google Scholar
• KonieczkowskiDJJohannessenCMGarrawayLAA convergence-based framework for cancer drug resistanceCancer Cell201833580181529763622
   PubMed Web of Science ®Google Scholar
• MuellnerMKUrasIZGappBVA chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancerNat Chem Biol201171178779321946274
   PubMed Web of Science ®Google Scholar
• ZhouGLiuZMyersJNTP53 mutations in head and neck squamous cell carcinoma and their impact on disease progression and treatment responseJ Cell Biochem2016117122682269227166782
   PubMed Web of Science ®Google Scholar
• PerriFIonnaFScarpatiGTranslational research: a future strategy for managing squamous cell carcinoma of the head and neck?Anticancer Agents Med Chem201818912201227
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas NetworkComprehensive genomic characterization of head and neck squamous cell carcinomasNature2015517753657658225631445
   PubMed Web of Science ®Google Scholar
• StranskyNEgloffAMTwardADThe mutational landscape of head and neck squamous cell carcinomaScience201133360461157116021798893
   PubMed Web of Science ®Google Scholar
• AgrawalNFrederickMJPickeringCRExome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in Notch1Science201133360461154115721798897
   PubMed Web of Science ®Google Scholar
• OmuraGAndoMEbiharaYThe prognostic value of TP53 mutations in hypopharyngeal squamous cell carcinomaBMC Cancer201717189829282038
   PubMedGoogle Scholar
• ShahnavazSARegeziJABradleyGDubéIDJordanRCP53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomasJ Pathol2000190441742210699989
   PubMed Web of Science ®Google Scholar
• ManterolaLAguirrePLarreaEMutational profiling can identify laryngeal dysplasia at risk of progression to invasive carcinomaSci Rep201881661329700339
   PubMedGoogle Scholar
• ZhaoDTahaneyWMMazumdarASavageMIBrownPHMolecularly targeted therapies for p53-mutant cancersCell Mol Life Sci201774224171418728643165
   PubMed Web of Science ®Google Scholar
• OckCYSonBKeamBIdentification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinomaJ Cancer Res Clin Oncol2016142487388326677030
   PubMed Web of Science ®Google Scholar
• NiehrFEderTPilzTMultilayered OMICs-based analysis of a head and neck cancer model of cisplatin resistance reveals intratumoral heterogeneity and treatment-induced clonal selectionClin Cancer Res201824115816829061642
   PubMed Web of Science ®Google Scholar
• GadhikarMASciutoMRAlvesMVChk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53Mol Cancer Ther20131291860187323839309
   PubMed Web of Science ®Google Scholar
• StrojanPKarnerKSmidLConcomitant chemoradiotherapy with mitomycin C and cisplatin in advanced unresectable carcinoma of the head and neck: phase I-II clinical studyInt J Radiat Oncol Biol Phys200872236537218394816
   PubMed Web of Science ®Google Scholar
• van HoutenVMLeemansCRKummerJAMolecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective studyClin Cancer Res200410113614362015173067
   PubMed Web of Science ®Google Scholar
• van HoutenVMLeemansCRKummerJAMolecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective studyClin Cancer Res200410113614362015173067
   PubMed Web of Science ®Google Scholar
• LiZGonzalezCLWangBCdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutant p53(R172H)J Pathol2016240222423427447534
   PubMed Web of Science ®Google Scholar
• ZhouGLiuZMyersJNTP53 mutations in head and neck squamous cell carcinoma and their impact on disease progression and treatment responseJ Cell Biochem2016117122682269227166782
   PubMed Web of Science ®Google Scholar
• PerroneFBossiPCortelazziBTP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinomaJ Clin Oncol201028576176620048189
   PubMed Web of Science ®Google Scholar
• HanelWMarchenkoNXuSYuSXWengWMollUTwo hot spot mutant p53 mouse models display differential gain of function in tumorigenesisCell Death Differ201320789890923538418
   PubMed Web of Science ®Google Scholar
• SongHHollsteinMXuYP53 gain-of-function cancer mutants induce genetic instability by inactivating ATMNat Cell Biol20079557358017417627
   PubMed Web of Science ®Google Scholar
• SkinnerHDSandulacheVCOwTJTP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescenceClin Cancer Res201218129030022090360
   PubMed Web of Science ®Google Scholar
• NeskeyDMOsmanAAOwTJEvolutionary action score of TP53 identifies high-risk mutations associated with decreased survival and increased distant metastases in head and neck cancerCancer Res20157571527153625634208
   PubMed Web of Science ®Google Scholar
• OsmanAAMonroeMMOrtega AlvesMVWee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescenceMol Cancer Ther201514260861925504633
   PubMed Web of Science ®Google Scholar
• OsmanAANeskeyDMKatsonisPEvolutionary action score of TP53 coding variants is predictive of platinum response in head and neck cancer patientsCancer Res20157571205121525691460
   PubMed Web of Science ®Google Scholar
• LambertJMMoshfeghAHainautPWimanKGBykovVJMutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosisOncogene20102991329133819946333
   PubMed Web of Science ®Google Scholar
• RieberMStrasberg-RieberMHypoxia, Mn-SOD and H(2)O(2) regulate p53 reactivation and PRIMA-1 toxicity irrespective of p53 status in human breast cancer cellsBiochem Pharmacol201284121563157022982566
   PubMed Web of Science ®Google Scholar
• ZandiRSelivanovaGChristensenCLGerdsTAWillumsenBMPoulsenHSPRIMA-1Met/APR-246 induces apoptosis and tumor growth delay in small cell lung cancer expressing mutant p53Clin Cancer Res20111792830284121415220
   PubMed Web of Science ®Google Scholar
• HerzogABianYvander BroekRPI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancerClin Cancer Res201319143808381923640975
   PubMed Web of Science ®Google Scholar
• FriedmanJNottinghamLDuggalPDeficient TP53 expression, function, and cisplatin sensitivity are restored by quinacrine in head and neck cancerClin Cancer Res20071322 Pt 16568657818006756
   PubMed Web of Science ®Google Scholar
• SinghBReddyPGGoberdhanAP53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomasGenes Dev200216898499311959846
   PubMed Web of Science ®Google Scholar
• AndersonRTKeysarSBBowlesDWThe dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomasMol Cancer Ther201312101994200523873848
   PubMed Web of Science ®Google Scholar
• TodorovaTAJordanovSHStanchevaGSMutational status of CDKN2A and TP53 genes in laryngeal squamous cell carcinomaPathol Oncol Res201521241342125149524
   PubMed Web of Science ®Google Scholar
• Ben-DayanMMOwTJBelbinTJNonpromoter methylation of the CDKN2A gene with active transcription is associated with improved locoregional control in laryngeal squamous cell carcinomaCancer Med20176239740728102032
   PubMed Web of Science ®Google Scholar
• LoyoMLiRJBettegowdaCLessons learned from next-generation sequencing in head and neck cancerHead Neck201335345446322907887
   PubMed Web of Science ®Google Scholar
• LarqueABCondeLHakimSP16(INK (4)a) overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative laryngeal squamous cell carcinomasVirchows Arch2015466437538225652585
   PubMed Web of Science ®Google Scholar
• PosnerMRLorchJHGoloubevaOSurvival and human papillomavirus in Oropharynx cancer in Tax 324: a subset analysis from an international phase III trialAnn Oncol20112251071107721317223
   PubMed Web of Science ®Google Scholar
• RischinDYoungRJFisherRPrognostic significance of p16INK4a and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trialJ Clin Oncol201028274142414820697079
   PubMed Web of Science ®Google Scholar
• ChungCHParkerJSKaracaGMolecular classification of head and neck squamous cell carcinomas using patterns of gene expressionCancer Cell20045548950015144956
   PubMed Web of Science ®Google Scholar
• JouAHessJEpidemiology and molecular biology of head and neck cancerOncol Res Treat201740632833228531899
   PubMed Web of Science ®Google Scholar
• HuangSHPerez-OrdonezBWeinrebINatural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancerOral Oncol2013491798522917550
   PubMed Web of Science ®Google Scholar
• RiekeDTKeilholzUSystemic treatment in HPV-induced recurrent or metastatic HNSCCRecent Results Cancer Res201720614916027699536
   PubMedGoogle Scholar
• LópezFSampedroTLlorenteJLHermsenMÁlvarez-MarcosCAlterations of p14 ARF, p15 INK4b, and p16 INK4a genes in primary laryngeal squamous cell carcinomaPathol Oncol Res2017231637127377733
   PubMed Web of Science ®Google Scholar
• SinhaPThorstadWTNussenbaumBDistant metastasis in p16-positive oropharyngeal squamous cell carcinoma: a critical analysis of patterns and outcomesOral Oncol2014501455124211084
   PubMed Web of Science ®Google Scholar
• TodorovaTAJordanovSHStanchevaGSMutational status of CDKN2A and TP53 genes in laryngeal squamous cell carcinomaPathol Oncol Res201521241342125149524
   PubMed Web of Science ®Google Scholar
• KangHKiessAChungCHEmerging biomarkers in head and neck cancer in the era of genomicsNat Rev Clin Oncol2015121112625403939
   PubMed Web of Science ®Google Scholar
• HuntJLBarnesLLewisJSMolecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applicationsEur Arch Otorhinolaryngol2014271221122323467835
   PubMed Web of Science ®Google Scholar
• NamazieAAlaviSOlopadeOICyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumorsLaryngoscope2002112347248112148857
   PubMed Web of Science ®Google Scholar
• NamazieAAlaviSOlopadeOICyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumorsLaryngoscope2002112347248112148857
   PubMed Web of Science ®Google Scholar
• MaahsGSMachadoDCJeckel-NetoEAMichaelsesVSCyclin D1 expression and cervical metastases in squamous cell carcinoma of the mouthBraz J Otorhinolaryngol2007731879417505605
   PubMedGoogle Scholar
• ZhangPZhangZZhouXQiuWChenFChenWIdentification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell lineBMC Cancer2006622416978399
   PubMed Web of Science ®Google Scholar
• NoelEEYeste-VelascoMMaoXThe association of CCND1 overexpression and cisplatin resistance in testicular germ cell tumors and other cancersAm J Pathol201017662607261520395447
   PubMed Web of Science ®Google Scholar
• Mielcarek-KuchtaDOlofssonJGolusinskiWP53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinomaEur Arch Otorhinolaryngol20032601054955414551784
   PubMed Web of Science ®Google Scholar
• TiedemannREMaoXShiCXIdentification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activityJ Clin Invest200811851750176418431519
   PubMed Web of Science ®Google Scholar
• KalishLHKwongRAColeIEGallagherRMSutherlandRLMusgroveEADeregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell linesClin Cancer Res200410227764777415570011
   PubMed Web of Science ®Google Scholar
• TimpsonPWilsonASLehrbachGMSutherlandRLMusgroveEADalyRJAberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinibCancer Res200767199304931417909038
   PubMed Web of Science ®Google Scholar
• KalishLHKwongRAColeIEGallagherRMSutherlandRLMusgroveEADeregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell linesClin Cancer Res200410227764777415570011
   PubMed Web of Science ®Google Scholar
• PickeringCRZhangJYooSYIntegrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic driversCancer Discov20133777078123619168
   PubMed Web of Science ®Google Scholar
• VermezovicJAdamowiczMSantarpiaLNotch is a direct negative regulator of the DNA-damage responseNat Struct Mol Biol201522541742425895060
   PubMed Web of Science ®Google Scholar
• TinhoferIBudachVSakiMTargeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiationEur J Cancer201657788626896955
   PubMed Web of Science ®Google Scholar
• TinhoferIStenzingerAEderTTargeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiationAnn Oncol201627122262226827681865
   PubMed Web of Science ®Google Scholar
• VettoreALRamnarayananKPooreGMutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevanceGenome Med201579826395002
   PubMed Web of Science ®Google Scholar
• CortelazziBVerderioPCiniselliCMReceptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinomaJ Oral Pathol Med201544973474525495427
   PubMed Web of Science ®Google Scholar
• SewellABrownBBiktasovaAReverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancerClin Cancer Res20142092300231124599934
   PubMed Web of Science ®Google Scholar
• FeldmanRGatalicaZKnezeticJMolecular profiling of head and neck squamous cell carcinomaHead Neck201638Suppl 1E1625E163826614708
   PubMed Web of Science ®Google Scholar
• LuiVWHedbergMLLiHFrequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkersCancer Discov20133776176923619167
   PubMed Web of Science ®Google Scholar
• ChauNGLiYYJoVYIncorporation of next-generation sequencing into routine clinical care to direct treatment of head and neck squamous cell carcinomaClin Cancer Res201622122939294926763254
   PubMed Web of Science ®Google Scholar
• NisaLHäfligerPPoliakováMPIK3CA hotspot mutations differentially impact responses to Met targeting in MET-driven and non-driven preclinical cancer modelsMol Cancer20171619328532501
   PubMedGoogle Scholar
• FokasEImJHHillSDual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculatureCancer Res201272123924822108822
   PubMed Web of Science ®Google Scholar
• SoulièresDFaivreSMesíaRBuparlisib and paclitaxel in patients with platinum-pretreated recurrent or metastatic squamous cell carcinoma of the head and neck (BERIL-1): a randomised, double-blind, placebo-controlled phase 2 trialLancet Oncol201718332333528131786
   PubMed Web of Science ®Google Scholar
• SeiwertTYZuoZKeckMKIntegrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomasClin Cancer Res201521363264125056374
   PubMed Web of Science ®Google Scholar
• ArnoldLEndersJThomasSMActivated HGF-c-Met axis in head and neck cancerCancers2017912E169:16929231907
   PubMed Web of Science ®Google Scholar
• PsyrriALeeJWPectasidesEPrognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern Cooperative Oncology Group E2303Clin Cancer Res201420113023303224700741
   PubMed Web of Science ®Google Scholar
• WangZMartinDMolinoloAAmTOR co-targeting in cetuximab resistance in head and neck cancers harboring PIK3CA and RAS mutations.J Natl Cancer Inst20141069
   Google Scholar
• MisiukiewiczKDangRPParidesMEndothelial growth factor receptor inhibitors in recurrent metastatic cancer of the head and neckHead Neck201638Suppl 1E2221E222825900280
   PubMedGoogle Scholar
• MartinDAbbaMCMolinoloAAThe head and neck cancer cell oncogenome: a platform for the development of precision molecular therapiesOncotarget20145198906892325275298
   PubMedGoogle Scholar
• AhmadPSanaJSlavikMSlampaPSmilekPSlabyOMicroRNAs involvement in radioresistance of head and neck cancerDis Markers2017201718
   Web of Science ®Google Scholar
• FlezarMSKirbisISPopovićKSStrojanPRadiosensitivity of squamous cell carcinoma metastases to the neck assessed by immunocytochemical profiling of fine-needle aspiration biopsy cell specimens: a pilot studyRadiother Oncol200993357558019850367
   PubMed Web of Science ®Google Scholar
• MetheetrairutCSlackFJMicroRNAs in the ionizing radiation response and in radiotherapyCurr Opin Genet Dev2013231121923453900
   PubMed Web of Science ®Google Scholar
• SummererINiyaziMUngerKChanges in circulating microR-NAs after radiochemotherapy in head and neck cancer patientsRadiat Oncol2013829624373621
   PubMed Web of Science ®Google Scholar
• BrandTMIidaMLutharNStarrMMHuppertEJWheelerDLNuclear EGFR as a molecular target in cancerRadiother Oncol2013108337037723830194
   PubMed Web of Science ®Google Scholar
• ToulanyMKasten-PisulaUBrammerIBlockage of epidermal growth factor receptor-phosphatidylinositol 3-kinase-Akt signaling increases radiosensitivity of K-ras mutated human tumor cells in vitro by affecting DNA repairClin Cancer Res200612134119412616818713
   PubMed Web of Science ®Google Scholar
• JanssensGORademakersSETerhaardCHAccelerated radiotherapy with carbogen and nicotinamide for laryngeal cancer: results of a phase III randomized trialJ Clin Oncol201230151777178322508814
   PubMed Web of Science ®Google Scholar
• SwinsonDEO’ByrneKJInteractions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancerClin Lung Cancer20067425025616512978
   PubMed Web of Science ®Google Scholar
• MoreiraJTobiasAO’BrienMPAgulnikMTargeted therapy in head and neck cancer: an update on current clinical developments in epidermal growth factor receptor-targeted therapy and immunothera-piesDrugs201777884385728382569
   PubMed Web of Science ®Google Scholar
• NijkampMMSpanPNTerhaardCHEpidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trialEur J Cancer201349153202320923867129
   PubMed Web of Science ®Google Scholar
• JuergensRABratmanSVTsaoMSBiology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neckCancer Treat Rev201754435728192747
   PubMed Web of Science ®Google Scholar
• VermorkenJBMesiaRRiveraFPlatinum-based chemotherapy plus cetuximab in head and neck cancerN Engl J Med2008359111116112718784101
   PubMed Web of Science ®Google Scholar
• BrauswetterDDánosKGurbiBCopy number gain of PIK3CA and Met is associated with poor prognosis in head and neck squamous cell carcinomaVirchows Arch2016468557958726832731
   PubMed Web of Science ®Google Scholar
• MilikSNLasheenDSSeryaRATAbouzidKAMHow to train your inhibitor: design strategies to overcome resistance to epidermal growth factor receptor inhibitorsEur J Med Chem201714213115128754471
   PubMed Web of Science ®Google Scholar
• KontićMMilovanovićJČolovićZEpidermal growth factor receptor (EGFR) expression in patients with laryngeal squamous cell carcinomaEur Arch Otorhinolaryngol2015272240140525294054
   PubMed Web of Science ®Google Scholar
• MarimuthuAChavanSSatheGIdentification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretomeBiochim Biophys Acta20131834112308231623665456
   PubMed Web of Science ®Google Scholar
• AnsellAJedlinskiAJohanssonACRobergKEpidermal growth factor is a potential biomarker for poor cetuximab response in tongue cancer cellsJ Oral Pathol Med201645191625677871
   PubMed Web of Science ®Google Scholar
• ZanottiLPadernoAPiazzaCEpidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancerLaryngoscope201712711E408E41428782189
   PubMed Web of Science ®Google Scholar
• van DijkLKBoermanOCKaandersJHBussinkJEpidermal growth factor receptor imaging in human head and neck cancer xenograftsActa Oncol20155491263126726248024
   PubMed Web of Science ®Google Scholar
• BeckTNGeorgopoulosRShagisultanovaEIEGFR and Rb1 as dual biomarkers in HPV-negative head and neck cancerMol Cancer Ther201615102486249727507850
   PubMed Web of Science ®Google Scholar
• RomanitanMNäsmanAMunck-WiklandEDalianisTRamqvistTEGFR and phosphorylated EGFR in relation to HPV and clinical outcome in tonsillar cancerAnticancer Res20133341575158323564800
   PubMed Web of Science ®Google Scholar
• SeiwertTYJagadeeswaranRFaoroLThe Met receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinomaCancer Res20096973021303119318576
   PubMed Web of Science ®Google Scholar
• NietoMAHuangRYJacksonRAThieryJPEMT: 2016Cell20161661214527368099
   PubMed Web of Science ®Google Scholar
• TsaiJHYangJEpithelial-mesenchymal plasticity in carcinoma metastasisGenes Dev201327202192220624142872
   PubMed Web of Science ®Google Scholar
• TamWLWeinbergRAThe epigenetics of epithelial-mesenchymal plasticity in cancerNat Med201319111438144924202396
   PubMed Web of Science ®Google Scholar
• SzturzPRaymondEFaivreSc-MET-mediated resistance to EGFR inhibitors in head and neck cancer: how to move from bench to bedsideOral Oncol201659e12e1427302885
   PubMed Web of Science ®Google Scholar
• CitronFArmeniaJFranchinGAn integrated approach identifies mediators of local recurrence in head and neck squamous carcinomaClin Cancer Res201723143769378028174235
   PubMed Web of Science ®Google Scholar
• SzturzPRaymondEAbitbolCAlbertSde GramontAFaivreSUnderstanding c-MET signalling in squamous cell carcinoma of the head & neckCrit Rev Oncol Hematol2017111395128259294
   PubMed Web of Science ®Google Scholar
• GarufiATrisciuoglioDPorruMA fluorescent curcumin-based Zn(II)-complex reactivates mutant (R175H and R273H) p53 in cancer cellsJ Exp Clin Cancer Res2013327224220325
   PubMed Web of Science ®Google Scholar
• CañadasIRojoFArumí-UríaMRoviraAAlbanellJArriolaEC-Met as a new therapeutic target for the development of novel anticancer drugsClin Transl Oncol201012425326020462834
   PubMed Web of Science ®Google Scholar
• Madoz-GúrpideJZazoSChamizoCActivation of Met pathway predicts poor outcome to cetuximab in patients with recurrent or metastatic head and neck cancerJ Transl Med20151328226319934
   PubMed Web of Science ®Google Scholar
• XuHStabileLPGubishCTGoodingWEGrandisJRSiegfriedJMDual blockade of EGFR and c-Met abrogates redundant signaling and proliferation in head and neck carcinoma cellsClin Cancer Res201117134425443821622718
   PubMed Web of Science ®Google Scholar
• SeiwertTYJagadeeswaranRFaoroLThe Met receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinomaCancer Res20096973021303119318576
   PubMed Web of Science ®Google Scholar
• StabileLPHeGLuiVWc-Src activation mediates erlotinib resistance in head and neck cancer by stimulating c-MetClin Cancer Res201319238039223213056
   PubMed Web of Science ®Google Scholar
• MoorenJJGültekinSEStraetmansJMP16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasiasInt J Cancer201413492108211724127203
   PubMed Web of Science ®Google Scholar
• WallineHMCareyTEGoudsmitCMHigh-risk HPV, biomarkers, and outcome in matched cohorts of head and neck cancer patients positive and negative for HIVMol Cancer Res201715217918827899422
   PubMed Web of Science ®Google Scholar
• OhnamiSOhshimaKNagashimaTComprehensive characterization of genes associated with the TP53 signal transduction pathway in various tumorsMol Cell Biochem20174311–2758528258440
   PubMed Web of Science ®Google Scholar
• VainshteinJMSpectorMEMcHughJBRefining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancerOral Oncol201450551351924565983
   PubMed Web of Science ®Google Scholar
• KanyilmazGEkinciOMugeACelikSOzturkFHPV-Associated p16INK4A Expression and Response to Therapy and Survival in Selected Head and Neck CancersAsian Pacific Journal of Cancer Prevention201516125325825640361
   PubMedGoogle Scholar
• SenBPengSSaigalBWilliamsMDJohnsonFMDistinct Interactions Between c-Src and c-Met in Mediating Resistance to c-Src Inhibition in Head and Neck CancerClin Cancer Res201117351452421106725
   PubMed Web of Science ®Google Scholar
• CasconeTXuLLinHYThe HGF/c-MET Pathway Is a Driver and Biomarker of VEGFR-inhibitor Resistance and Vascular Remodeling in Non-Small Cell Lung CancerClin Cancer Res20172318489550127435400
   PubMed Web of Science ®Google Scholar
• HoadleyKAYauCHinoueTCell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancerCell201845173229130429625048
   PubMed Web of Science ®Google Scholar
• EllrottKBaileyMHSaksenaGScalable open science approach for mutation calling of tumor exomes using multiple genomic pipelinesCell systems20183286327128129596782
   PubMed Web of Science ®Google Scholar
• TaylorAMShihJHaGGenomic and functional approaches to understanding cancer aneuploidyCancer Cell20184933467668929622463
   PubMed Web of Science ®Google Scholar
• GaoQLiangWWFoltzSMDriver fusions and their implications in the development and treatment of human cancersCell reports20184323122733829617662
   PubMed Web of Science ®Google Scholar
• LiuJLichtenbergTHoadleyKAAn integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analyticsCell201845173240041629625055
   PubMed Web of Science ®Google Scholar
• Sanchez-VegaFMinaMArmeniaJOncogenic Signaling Pathways in The Cancer Genome AtlasCell201845173232133729625050
   PubMed Web of Science ®Google Scholar
• LiTWenHBraytonCEpidermal growth factor receptor and notch pathways participate in the tumor suppressor function of gamma-secretaseJ Biol Chem200728244322643227317827153
   PubMed Web of Science ®Google Scholar
• GaoJAksoyBADogrusozUIntegrative analysis of complex cancer genomics and clinical profiles using the cBioPortalSci Signal20136269l1
   Web of Science ®Google Scholar
• CeramiEGaoJDogrusozUThe cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics dataCancer Discov20122540140422588877
   PubMed Web of Science ®Google Scholar